BOEHRINGER INGELHEIM FDA Approval Oct. 14, 2022, 02:42 UTC 26 0 comments FDA approve EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE Comment Full text
BOEHRINGER INGELHEIM FDA Approval Oct. 14, 2022, 02:42 UTC 28 0 comments FDA approve EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE Comment Full text
BOEHRINGER INGELHEIM FDA Approval Oct. 14, 2022, 02:42 UTC 24 0 comments FDA approve EMPAGLIFLOZIN; LINAGLIPTIN Comment Full text
JANSSEN PHARMS FDA Approval Oct. 14, 2022, 02:42 UTC 26 0 comments FDA approve CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE Comment Full text
ASTRAZENECA AB FDA Approval Oct. 14, 2022, 02:42 UTC 25 0 comments FDA approve DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE Comment Full text
BOEHRINGER INGELHEIM FDA Approval Oct. 14, 2022, 02:42 UTC 23 0 comments FDA approve EMPAGLIFLOZIN Comment Full text
JANSSEN PHARMS FDA Approval Oct. 14, 2022, 02:42 UTC 29 0 comments FDA approve CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE Comment Full text
JANSSEN PHARMS FDA Approval Oct. 14, 2022, 02:42 UTC 23 0 comments FDA approve CANAGLIFLOZIN Comment Full text
ASTRAZENECA AB FDA Approval Oct. 14, 2022, 02:42 UTC 23 0 comments FDA approve DAPAGLIFLOZIN Comment Full text
ANI PHARMS FDA Approval Oct. 14, 2022, 02:42 UTC 27 0 comments FDA approve LITHIUM CARBONATE Comment Full text